Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation

BACKGROUND: Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but the literature is limited. CASE: Two pediatric patients were diagnosed with PVB19 infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattani, Nabila, Matheny, Christina, Eckrich, Michael J., Madden, Lisa M., Quigg, Troy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789606/
https://www.ncbi.nlm.nih.gov/pubmed/33932151
http://dx.doi.org/10.1002/cnr2.1403
Descripción
Sumario:BACKGROUND: Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but the literature is limited. CASE: Two pediatric patients were diagnosed with PVB19 infection around the time of allo‐HSCT graft failure. Both cases were secondary graft failure and required second allo‐HSCT. CONCLUSION: There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo‐HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo‐HSCT graft failure.

Ejemplares similares